Diabetes Treatment

U.S. FDA gives nod to OTC use of insulin-dosing technology

Published in Biotech Business Week, November 29th, 2004

Dimensional Dosing Systems, Inc., announced that the company has received FDA (U.S. Food and Drug Administration) approval for over the counter (OTC) patient use of the company's insulin-dosing technology in clinical trials.

The Intelligent Dosing System (IDS) incorporates patient-specific dosing data into a proprietary model that calculates the optimal next dose needed to achieve a desired target level or goal.

The IDS requires only two prior dose and response inputs to calculate the optimal next dose and is effective in the simultaneous dosing of multiple agents.

The company is in active discussions regarding the utilization of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Biotech Business Week

Source: Biotech Business Week (2004-11-29)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry